Editor Note: Understanding the importance of this timely topic and to ensure that research is made available to the wider academic community, IGI Global has made a chapter of the featured publicaton complimentary to access through September 10.
"Historical and Epidemiological Analyses on the Impact of Infectious Disease on Society was written to provide context to the COVID-19 pandemic, and now may help provide context to the spread of the monkeypox virus. Apparent exponential growth in monkeypox cases, suggested by case counts in Africa rising since the 1970s, has recently expanded worldwide. The outbreak risks raising stigmatization because it currently appears to be spreading in the population outside of Africa largely among men who have sex with men. The impact of monkeypox may vary around the globe. However, much recent literature emphasizes that cases at the forefront of the current outbreak are generally mild. A characteristic symptom is rash, but fever, chills, and lymphadenopathy may also be present. Smallpox vaccines have efficacy against monkeypox, via genetic similarities in the underlying pathogens, while antivirals and vaccinia immune globulin intravenous are indicated as treatments in the course of more significant cases. Because monkeypox is caused by a double-stranded DNA virus, its mutation rate is expected to be low compared to the single-stranded COVID-19 RNA virus. How the outbreak will resolve is yet unknown, and its progression is linked to social and biological factors that have influenced disease impact throughout history.”
In response to the timeliness and importance of this topic, see these Open Access (OA) articles covering the impacts and research surrounding infections diseases, including COVID-19. Please feel free to integrate these resources into your research and share them across your network.
Founded in 1988 and headquartered in Hershey, Pennsylvania, USA with a subsidiary office (IGI Science and Technology, Ltd.), operating out of Beijing, China, IGI Global is a leading medium-sized independent academic publisher of international scientific research. They are committed to facilitating the discovery of pioneering research that enhances and expands the body of knowledge available to the research community through traditional and open access publishing workflows. Working in close collaboration with expert researchers and professionals from leading institutions, IGI Global publishes quality peer-reviewed content across 350+ topics in 11 core subject areas, including business, computer science, education, engineering, healthcare, social sciences, and more. With over 150,000+ industry-leading researchers and experts worldwide contributing to IGI Global’s publications, they ensure that each contains the most emerging and timeliest research. Learn more about IGI Global here.
Emma Baronak (717) 533-8845 ext. 183ebaronak@igi-global.comwww.igi-global.com